287 related articles for article (PubMed ID: 17344214)
1. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.
Saxena NK; Vertino PM; Anania FA; Sharma D
J Biol Chem; 2007 May; 282(18):13316-25. PubMed ID: 17344214
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin.
Yin N; Wang D; Zhang H; Yi X; Sun X; Shi B; Wu H; Wu G; Wang X; Shang Y
Cancer Res; 2004 Aug; 64(16):5870-5. PubMed ID: 15313931
[TBL] [Abstract][Full Text] [Related]
3. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
[TBL] [Abstract][Full Text] [Related]
4. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1.
Fernando R; Foster JS; Bible A; Ström A; Pestell RG; Rao M; Saxton A; Baek SJ; Yamaguchi K; Donnell R; Cekanova M; Wimalasena J
J Biol Chem; 2007 Sep; 282(39):28864-28873. PubMed ID: 17670745
[TBL] [Abstract][Full Text] [Related]
6. Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.
Giordano C; Vizza D; Panza S; Barone I; Bonofiglio D; Lanzino M; Sisci D; De Amicis F; Fuqua SA; Catalano S; Andò S
Mol Oncol; 2013 Jun; 7(3):379-91. PubMed ID: 23228483
[TBL] [Abstract][Full Text] [Related]
7. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
[TBL] [Abstract][Full Text] [Related]
8. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
Hilton TL; Li Y; Dunphy EL; Wang EH
Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
[TBL] [Abstract][Full Text] [Related]
9. [Leptin promotes the expression of hTERT via STAT3 in breast cancer cells].
Li SS; Sheng J; Yuan ZN; Wang XC; Zhao TS; Ren H; Hao JH
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2386-8. PubMed ID: 23158658
[TBL] [Abstract][Full Text] [Related]
10. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
[TBL] [Abstract][Full Text] [Related]
11. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways.
Li Z; Shen J; Wu WK; Yu X; Liang J; Qiu G; Liu J
PLoS One; 2012; 7(12):e53176. PubMed ID: 23300886
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
13. The activation of leptin-mediated survivin is limited by the inducible suppressor SOCS-3 in MCF-7 cells.
Palianopoulou M; Papanikolaou V; Stefanou N; Tsezou A
Exp Biol Med (Maywood); 2011 Jan; 236(1):70-6. PubMed ID: 21239736
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
[TBL] [Abstract][Full Text] [Related]
17. STAT3 down-regulates the expression of cyclin D during liver development.
Matsui T; Kinoshita T; Hirano T; Yokota T; Miyajima A
J Biol Chem; 2002 Sep; 277(39):36167-73. PubMed ID: 12147685
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
19. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
Ray A; Nkhata KJ; Cleary MP
Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372
[TBL] [Abstract][Full Text] [Related]
20. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
